How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    a. Has all of the relevant evidence been taken into account?
  • Question on Consultation

    b. Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?
  • Question on Consultation

    c. Are the recommendations sound and a suitable basis for guidance to the NHS?
  • Question on Consultation

    d. Are there any aspects of the recommendations that need particular consideration to ensure we avoid unlawful discrimination against any group of people on the grounds of age, disability, gender reassignment, pregnancy and maternity, race, religion or belief, sex or sexual orientation?

4 Evaluation committee members and NICE project team

Evaluation committee members

This topic was evaluated as a single technology appraisal by the highly specialised technologies evaluation committee. The highly specialised technologies evaluation committee and the 4 technology appraisal committees are standing advisory committees of NICE. Committee members are asked to declare any interests in the technology being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

The minutes of each evaluation committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.

Chair

Paul Arundel

Highly specialised technologies evaluation committee

NICE project team

Each evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser, a project manager, and an associate director or principal technical adviser.

Emma Douch
Technical lead

Alan Moore
Technical adviser

Thomas Feist
Project manager

Christian Griffiths
Principal technical adviser

ISBN: [to be added at publication]